EUVIMEDEUVIMED entdecken
Crossref

A rare BRCA1 alternative missense mutation identified in African American women with breast cancer

Desta Beyene, Luisel J. Ricks-Santi, Delisha A. Stewart, Muneer Abbas, Andrea Hayes-Dixon, Ahmed Ali, Olakunle O. Kassim, Robin Williams, Steven Nagel, Babak Shokrani, Robert L. Copeland, Yasmine M. Kanaan

Journal of Breast Cancer Research · 2025

DOI: 10.46439/breastcancer.5.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Cancer Research, 2025. Verfasst von Desta Beyene und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hereditary breast cancer is most commonly caused by inherited mutations in the BRCA1 or BRCA2 genes, which significantly increase the risk of breast and ovarian cancers.

Methods

Denaturing High-Performance Liquid Chromatography (DHPLC) and DNA sequencing were used to analyze BRCA1 mutations, missense variants, polymorphisms, haplotypes, and large genomic rearrangements in ninety-nine African American (AA) patients from high-risk families. Sorting Intolerant From Tolerant (SIFT) analysis was applied to predict the functional impact of amino acid substitutions. Potential effects on splicing were evaluated by examining disruption of conserved exonic splicing enhancer (ESE) elements or canonical splice site sequences.

Results

DHPLC and sequencing analysis identified a deleterious protein-truncating BRCA1 mutation, 5296delGAAA, in two unrelated patients diagnosed with bilateral and early-onset breast cancer, both with extensive family histories of breast and ovarian cancers. A second pathogenic variant, IVS16+6T>C, was detected in two additional patients with early-onset or bilateral breast cancer and a strong familial history. Three missense variants (Ile379Met, Glu1210Lys, Glu1794Asp), predicted to be deleterious by SIFT, were identified, including two exon 22 variants (Gln1785His and Glu1794Asp) likely to affect splicing. A rare silent variant, 884G>A (Glu255), located in an alternative exon 11 ESE, was identified in one patient and is predicted to abolish tissue-specific splicing. Multiple coding and non-coding polymorphisms were detected, and haplotype analysis revealed two predominant BRCA1 haplotypes among 64% of AA patients, suggesting population-specific allele distributions. MLPA analysis of 26 patients heterozygous for the BRCA1 exon 11 Pro871Leu polymorphism revealed a novel large deletion encompassing exons 1a, 1b, and 2, extending into the promoter region. This deletion, supported by linkage disequilibrium analysis, represents the first report of such a mutation in an AA family. Preliminary MLPA screening of an additional 40 patients and 2 cancer-free controls identified a potential exon 17 duplication in one case, warranting further investigation.

Conclusion

These findings highlight the complexity and diversity of BRCA1 alterations in AA breast cancer patients and underscore the importance of comprehensive genetic screening in this population to enhance risk assessment and guide clinical management.

Zitieren

APA

Beyene, D., Ricks-Santi, L. J., Stewart, D. A., Abbas, M., Hayes-Dixon, A., Ali, A., Kassim, O. O., Williams, R., Nagel, S., Shokrani, B., Copeland, R. L., & Kanaan, Y. M. (2025). A rare BRCA1 alternative missense mutation identified in African American women with breast cancer. Journal of Breast Cancer Research. https://doi.org/10.46439/breastcancer.5.032

Vancouver

Beyene D, Ricks-Santi LJ, Stewart DA, Abbas M, Hayes-Dixon A, Ali A, et al. A rare BRCA1 alternative missense mutation identified in African American women with breast cancer. Journal of Breast Cancer Research. 2025. doi:10.46439/breastcancer.5.032

BibTeX
@article{Beyene2025,
  author = {Beyene, Desta and Ricks-Santi, Luisel J. and Stewart, Delisha A. and Abbas, Muneer and Hayes-Dixon, Andrea and Ali, Ahmed and Kassim, Olakunle O. and Williams, Robin and Nagel, Steven and Shokrani, Babak and Copeland, Robert L. and Kanaan, Yasmine M.},
  title = {A rare BRCA1 alternative missense mutation identified in African American women with breast cancer},
  journal = {Journal of Breast Cancer Research},
  year = {2025},
  doi = {10.46439/breastcancer.5.032}
}
Kostenlos starten →